Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gene therapy for Parkinson's disease

P Horellou1, J Mallet

  • 1C 9923 CNRS, Laboratoire de Génétique Moleculaire de la Neurotransmission et des Processus Dégénératifs, Hopital de la Pitié Salpêtriere, Bâtiment CERVI, Paris, France.

Molecular Neurobiology
|December 13, 1997
PubMed
Summary

Gene therapy offers a promising treatment for neurological diseases like Parkinson's. Adenovirus vectors show potential for both in vivo and ex vivo gene transfer, with sustained expression in the brain.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Polygenic basis of incipient reproductive isolation in hybridizing populations is revealed by pangenomic and epigenetic divergence.

bioRxiv : the preprint server for biology·2025
Same author

Frequency and clinical relevance of MOG-antibodies in CSF in pediatric patients with MOG antibody-associated diseases.

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society·2024
Same author

A model of hemodialysis after acute kidney injury in rats.

Intensive care medicine experimental·2023
Same author

Radiographic measurement of the congruence angle according to Merchant: validity, reproducibility, and limits.

Knee surgery & related research·2023
Same author

3-year incidence and predictors of metabolic syndrome in schizophrenia in the national FACE-SZ cohort.

Progress in neuro-psychopharmacology & biological psychiatry·2022
Same author

The impact of parent history of severe mental illness on schizophrenia outcomes: results from the real-world FACE-SZ cohort.

European archives of psychiatry and clinical neuroscience·2022

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Biotechnology

Background:

  • Gene therapy presents a novel therapeutic avenue for neurological disorders.
  • Neurotrophic factors and neurotransmitter-synthesizing enzymes underpin current gene therapy for Parkinson's disease.

Purpose of the Study:

  • To evaluate the potential of viral vectors for gene therapy in neurological diseases.
  • To compare the efficacy and safety of different gene transfer methods.

Main Methods:

  • Utilizing recombinant retroviruses for ex vivo gene therapy.
  • Employing adenovirus vectors for in vivo gene transfer to the brain.
  • Assessing gene expression persistence and inflammatory responses.

Main Results:

  • Recombinant retroviruses are efficient for in vitro genetic modification and ex vivo transplantation.
  • Adenovirus vectors enable both in vivo and ex vivo gene transfer to neural cells.
  • Adenoviral vector expression persists for months in the brain with minimal inflammation.

Conclusions:

  • Adenovirus vectors demonstrate significant potential for in vivo gene therapy in neurological conditions.
  • Further improvements in vector technology are needed for long-term, regulatable transgene expression in clinical applications.

Related Experiment Videos